BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25801503)

  • 1. Norwegian elderly patients' need for drug information and attitudes towards medication use reviews in community pharmacies.
    Mamen AV; Håkonsen H; Kjome RL; Gustavsen-Krabbesund B; Toverud EL
    Int J Pharm Pract; 2015 Dec; 23(6):423-8. PubMed ID: 25801503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of patient interviews to the identification of drug-related problems in home medication review.
    Kwint HF; Faber A; Gussekloo J; Bouvy ML
    J Clin Pharm Ther; 2012 Dec; 37(6):674-80. PubMed ID: 22861493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' knowledge of new medicines after discharge from hospital: What are the effects of hospital-based discharge counseling and community-based medicines use reviews (MURs)?
    Elson R; Cook H; Blenkinsopp A
    Res Social Adm Pharm; 2017; 13(3):628-633. PubMed ID: 27283244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completeness of medication reviews provided by community pharmacists.
    Kwint HF; Faber A; Gussekloo J; Bouvy ML
    J Clin Pharm Ther; 2014 Jun; 39(3):248-52. PubMed ID: 24521180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do patients need to know? A study to assess patients' satisfaction with information about medicines.
    Twigg MJ; Bhattacharya D; Clark A; Patel R; Rogers H; Whiteside H; Yaqoob M; Wright DJ
    Int J Pharm Pract; 2016 Aug; 24(4):229-36. PubMed ID: 26875728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-provider communication about medication use at the community pharmacy counter.
    van Dijk M; Blom L; Koopman L; Philbert D; Koster E; Bouvy M; van Dijk L
    Int J Pharm Pract; 2016 Feb; 24(1):13-21. PubMed ID: 25988371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacists' attitudes towards medicines use reviews and factors affecting the numbers performed.
    Latif A; Boardman H
    Pharm World Sci; 2008 Oct; 30(5):536-43. PubMed ID: 18288585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.
    Uhl MC; Muth C; Gerlach FM; Schoch GG; Müller BS
    BMC Fam Pract; 2018 Jan; 19(1):3. PubMed ID: 29304725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Slovenian community pharmacist counseling to patients' knowledge about their prescription medicines: a cross-sectional study.
    Horvat N; Kos M
    Croat Med J; 2015 Feb; 56(1):41-9. PubMed ID: 25727041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication use review in Qatar: are community pharmacists prepared for the extended professional role?
    Babiker AH; Carson L; Awaisu A
    Int J Clin Pharm; 2014 Dec; 36(6):1241-50. PubMed ID: 25293711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the patient perspective of the English community pharmacy Medicines Use Review (MUR).
    Latif A; Boardman HF; Pollock K
    Res Social Adm Pharm; 2013; 9(6):949-57. PubMed ID: 23506650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
    Nusair MB; Guirguis LM
    Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project.
    Seidling HM; Send AFJ; Bittmann J; Renner K; Dewald B; Lange D; Bruckner T; Haefeli WE
    Res Social Adm Pharm; 2017 Nov; 13(6):1127-1134. PubMed ID: 27816566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia.
    Vučićević KM; Miljković BR; Golubović BC; Jovanović MN; Vezmar Kovačević SD; Ćulafić MD; Kovačević MM; de Gier JJ
    Eur J Gen Pract; 2018 Dec; 24(1):19-25. PubMed ID: 29164957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication review and patient counselling at discharge from the hospital by community pharmacists.
    Hugtenburg JG; Borgsteede SD; Beckeringh JJ
    Pharm World Sci; 2009 Dec; 31(6):630-7. PubMed ID: 19649720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.
    Bryant LJ; Coster G; Gamble GD; McCormick RN
    Int J Pharm Pract; 2011 Apr; 19(2):94-105. PubMed ID: 21385240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medicines use review in patients with chronic skin diseases: are pharmacists doing them and how confident are they?
    Tucker R
    Int J Pharm Pract; 2013 Jun; 21(3):202-4. PubMed ID: 23418738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.